Display options
Cite
Papi A, Jesenak M, Alfano F, et al. The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy. 2021;doi: 10.1111/all.15131.
Papi, A., Jesenak, M., Alfano, F., G Peroni, D., Baraldi, F., & Diamant, Z. (2021). The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy, . https://doi.org/10.1111/all.15131
Papi, Alberto, et al. "The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management." Allergy vol. (2021). doi: https://doi.org/10.1111/all.15131
Papi A, Jesenak M, Alfano F, G Peroni D, Baraldi F, Diamant Z. The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management. Allergy. 2021 Oct 06; doi: 10.1111/all.15131. Epub 2021 Oct 06. PMID: 34614223.
Copy Download .nbib Format: NLM
Share it on

Allergy. 2021 Oct 06; doi: 10.1111/all.15131. Epub 2021 Oct 06.

The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management.

Allergy

Alberto Papi, Milos Jesenak, Franco Alfano, Diego G Peroni, Federico Baraldi, Zuzana Diamant

Affiliations

  1. Department of Translational Medicine, Respiratory Medicine, University of Ferrara and Emergency Department, University Hospital, Ferrara, Italy.
  2. Department of Paediatrics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.
  3. Department of Clinical Immunology and Allergology, University Teaching Hospital in Martin, Martin, Slovakia.
  4. Department of Clinical and Experimental Medicine, Pediatric Clinic, AOUP, University of Pisa, University Hospital, Pisa, Italy.
  5. Department of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.
  6. Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden.
  7. Department Clin Pharm & Pharmacol, University Groningen, University Medical Center Groningen, Groningen, Netherlands.

PMID: 34614223 DOI: 10.1111/all.15131

[No abstract available.]

References

  1. Global Initiative for Asthma. Global strategy for asthma management and prevention 2021. https://ginasthma.org/gina-reports/. Last accessed 15 September 2021. - PubMed
  2. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160:594-599. - PubMed
  3. Sobieraj DM, Weeda ER, Nguyen E, et al. Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. JAMA. 2018;319:1485-1496. - PubMed
  4. Papi A, Canonica GW, Maestrelli P, et al. BEST Study Group Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356:2040-2052. - PubMed
  5. O’Byrne PM, Fitzgerald JM, Bateman ED, et al. Inhaled combined budesonide-formoterol as needed in mild asthma. N Engl J Med. 2018;378(20):1865-1876. - PubMed
  6. Beasley R, Holliday M, Reddel HK, et al. Controlled trial of budesonide-formoterol as needed for mild asthma. N Engl J Med. 2019;380(21):2020-2030. - PubMed
  7. Papi A, Braithwaite I, Ebmeier S, et al. Budesonide-formoterol Reliever Therapy in Intermittent versus Mild Persistent Asthma. Eur Respir J. 2021;57(2):2003064. - PubMed
  8. Chipps BE, Albers FC, Reilly L, Johnsson E, Cappelletti C, Papi A. Evaluation of the Efficacy and Safety of As-Needed PT027 Budesonide/Albuterol MDI) Compared to As-Needed Albuterol MDI in Adults and Children 4 Years of Age or Older with Uncontrolled Moderate to Severe Asthma: Design of the Mandala Study. Am J Respir Crit Care Med. 2020;201:A3015. - PubMed
  9. https://avillionllp.com/avillion-announces-positive-results-in-mandala-and-denali-phase-iii-trials-of-astrazenecas-pt027-a-fixed-dose-combination-of-albuterol-and-budesonide-demonstrating-significant-benefits-for. Last accessed 15 September 2021. - PubMed
  10. Crossingham I, Turner S, Ramakrishnan S, et al. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database Syst Rev. 2021;5(5):CD013518. - PubMed

Publication Types